Dr. Abbott is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2 Dudley St
Suite 360
Providence, RI 02905Phone+1 401-444-4581Fax+1 401-444-8158
Education & Training
- Yale-New Haven Medical CenterFellowship, Cardiovascular Disease, 1999 - 2004
- Yale-New Haven Medical CenterResidency, Internal Medicine, 1995 - 1999
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1995
Certifications & Licensure
- RI State Medical License 2004 - 2026
- CT State Medical License 1998 - 2005
- American Board of Internal Medicine Interventional Cardiology
Clinical Trials
- IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction Start of enrollment: 2012 Apr 01
- Tailored Antiplatelet Therapy Following PCI Start of enrollment: 2013 May 01
- Myocardial Ischemia and Transfusion Start of enrollment: 2017 Apr 25
- Join now to see all
Publications & Presentations
PubMed
- 19 citationsCalpain inhibition improves collateral-dependent perfusion in a hypercholesterolemic swine model of chronic myocardial ischemiaAshraf A. Sabe, Brittany A. Potz, Nassrene Y. Elmadhun, Yuhong Liu, Jun Feng
The Journal of Thoracic and Cardiovascular Surgery. 2016-01-01 - 48 citationsCoronary Stents: History, Design, and ConstructionTorrey Schmidt, J. Abbott
Journal of Clinical Medicine. 2018-05-29 - 12 citationsMeta-Analysis Comparing Outcomes With Bifurcation Percutaneous Coronary Intervention Techniques.Ayman Elbadawi, Mina Shnoda, Alexander Dang, Mohamed Gad, Mohamed Abdelazeem
The American Journal of Cardiology. 2022-02-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: